BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 16392608)

  • 41. Estimating glomerular filtration rate in kidney donors: a model constructed with renal volume measurements from donor CT scans.
    Herts BR; Sharma N; Lieber M; Freire M; Goldfarb DA; Poggio ED
    Radiology; 2009 Jul; 252(1):109-16. PubMed ID: 19435940
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serum creatinine in patients with advanced liver disease is of limited value for identification of moderate renal dysfunction: are the equations for estimating renal function better?
    MacAulay J; Thompson K; Kiberd BA; Barnes DC; Peltekian KM
    Can J Gastroenterol; 2006 Aug; 20(8):521-6. PubMed ID: 16955148
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risk of contrast-induced nephropathy for patients receiving intravenous vs. intra-arterial iodixanol administration.
    Tong GE; Kumar S; Chong KC; Shah N; Wong MJ; Zimmet JM; Wang ZJ; Yee J; Fu Y; Yeh BM
    Abdom Radiol (NY); 2016 Jan; 41(1):91-9. PubMed ID: 26830615
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identifying outpatients with renal insufficiency before contrast-enhanced CT by using estimated glomerular filtration rates versus serum creatinine levels.
    Herts BR; Schneider E; Poggio ED; Obuchowski NA; Baker ME
    Radiology; 2008 Jul; 248(1):106-13. PubMed ID: 18458249
    [TBL] [Abstract][Full Text] [Related]  

  • 45. What are radiologists doing to prevent contrast-induced nephropathy (CIN) compared with measures supported by current evidence? A survey of European radiologists on CIN associated with computed tomography.
    Fishman EK; Reddan D
    Acta Radiol; 2008 Apr; 49(3):310-20. PubMed ID: 18365820
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The ratio of contrast volume to glomerular filtration rate predicts in-hospital and six-month mortality in patients undergoing primary angioplasty for ST-elevation myocardial infarction.
    Çiçek G; Bozbay M; Açıkgöz SK; Altay S; Uğur M; Köroğlu B; Uyarel H
    Cardiol J; 2015; 22(1):101-7. PubMed ID: 24671903
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The lack of benefit of a combination of an angiotensin receptor blocker and calcium channel blocker on contrast-induced nephropathy in patients with chronic kidney disease.
    Oguzhan N; Cilan H; Sipahioglu M; Unal A; Kocyigit I; Kavuncuoglu F; Arikan T; Akpek M; Elcik D; Sahin O; Gulme E; Pala C; Tokgoz B; Utas C; Oguzhan A; Oymak O
    Ren Fail; 2013; 35(4):434-9. PubMed ID: 23413781
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Frequency and risk factors of contrast-induced nephropathy after cardiac catheterization in type II diabetic patients: a study among Egyptian patients.
    Sany D; Refaat H; Elshahawy Y; Mohab A; Ezzat H
    Ren Fail; 2014 Mar; 36(2):191-7. PubMed ID: 24138570
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Administration of contrast media just before cisplatin-based chemotherapy increases cisplatin-induced nephrotoxicity.
    Sendur MA; Aksoy S; Yaman S; Arik Z; Tugba Kos F; Akinci MB; Civelek B; Yildirim Ozdemir N; Uncu D; Zengin N
    J BUON; 2013; 18(1):274-80. PubMed ID: 23613416
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of N-acetylcysteine for prevention of contrast nephropathy in patients with moderate to severe renal insufficiency: a randomized trial.
    Fung JW; Szeto CC; Chan WW; Kum LC; Chan AK; Wong JT; Wu EB; Yip GW; Chan JY; Yu CM; Woo KS; Sanderson JE
    Am J Kidney Dis; 2004 May; 43(5):801-8. PubMed ID: 15112170
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preventive effects of anisodamine against contrast-induced nephropathy in type 2 diabetics with renal insufficiency undergoing coronary angiography or angioplasty.
    Geng W; Fu XH; Gu XS; Wang YB; Wang XC; Li W; Jiang YF; Hao GZ; Fan WZ; Xue L
    Chin Med J (Engl); 2012 Oct; 125(19):3368-72. PubMed ID: 23044290
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Differences between the glomerular filtration rate estimated by the MDRD equation and the measurement of creatinine and urea clearance in unselected patients with terminal renal insufficiency].
    Caravaca F; Arrobas M; Luna E; Naranjo M; Pizarro JL; Sánchez-Casado E
    Nefrologia; 2002; 22(5):432-7. PubMed ID: 12497744
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of diabetic and pre-diabetic state on development of contrast-induced nephropathy in patients with chronic kidney disease.
    Toprak O; Cirit M; Yesil M; Bayata S; Tanrisev M; Varol U; Ersoy R; Esi E
    Nephrol Dial Transplant; 2007 Mar; 22(3):819-26. PubMed ID: 17090607
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serum albumin, but not glycated albumin was a potent factor affecting the performance of GFR equation based on serum creatinine.
    Horio M; Imai E; Yasuda Y; Watanabe T; Yokoyama H; Makino H; Matsuo S
    Clin Exp Nephrol; 2015 Apr; 19(2):284-92. PubMed ID: 24907068
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The incidence of contrast-induced nephropathy in trauma patients.
    Hipp A; Desai S; Lopez C; Sinert R
    Eur J Emerg Med; 2008 Jun; 15(3):134-9. PubMed ID: 18460952
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Contrast-induced nephropathy (CIN) of patients with renal dysfunction in CT examination.
    Fukushima Y; Miyazawa H; Nakamura J; Taketomi-Takahashi A; Suto T; Tsushima Y
    Jpn J Radiol; 2017 Aug; 35(8):427-431. PubMed ID: 28528465
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Urinary cGMP predicts major adverse renal events in patients with mild renal impairment and/or diabetes mellitus before exposure to contrast medium.
    Chaykovska L; Heunisch F; von Einem G; Hocher CF; Tsuprykov O; Pavkovic M; Sandner P; Kretschmer A; Chu C; Elitok S; Stasch JP; Hocher B
    PLoS One; 2018; 13(4):e0195828. PubMed ID: 29649334
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Contrast-induced nephropathy: controlled study by differential GFR measurement in hospitalized patients.
    Erselcan T; Egilmez H; Hasbek Z; Tandogan I
    Acta Radiol; 2012 Mar; 53(2):228-32. PubMed ID: 22139722
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Baseline renal function screening.
    Lameire N; Adam A; Becker CR; Davidson C; McCullough PA; Stacul F; Tumlin J;
    Am J Cardiol; 2006 Sep; 98(6A):21K-26K. PubMed ID: 16949377
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epidemiology of contrast material-induced nephropathy in the era of hydration.
    Balemans CE; Reichert LJ; van Schelven BI; van den Brand JA; Wetzels JF
    Radiology; 2012 Jun; 263(3):706-13. PubMed ID: 22535561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.